Myocardin‐related transcription factor contributes to renal fibrosis through the regulation of extracellular microenvironment surrounding fibroblasts

Abstract Fibroblast accumulation and extracellular matrix (ECM) deposition are common critical steps for the progression of organ fibrosis, but the precise molecular mechanisms remain to be fully investigated. We have previously demonstrated that lysophosphatidic acid contributes to organ fibrosis through the production of connective tissue growth factor (CTGF) via actin cytoskeleton‐dependent signaling, myocardin‐related transcription factor family (MRTF) consisting of MRTF‐A and MRTF‐B‐serum response factor (SRF) pathway. In this study, we investigated the role of the MRTF‐SRF pathway in the development of renal fibrosis, focusing on the regulation of ECM‐focal adhesions (FA) in renal fibroblasts. Here we showed that both MRTF‐A and ‐B were required for the expressions of ECM‐related molecules such as lysyl oxidase family members, type I procollagen and fibronectin in response to transforming growth factor (TGF)‐β 1 . TGF‐β 1 ‐MRTF‐SRF pathway induced the expressions of various components of FA such as integrin α subunits (α v , α 2 , α 11 ) and β subunits (β 1 , β 3 , β 5 ) as well as integrin‐linked kinase (ILK). On the other hand, the blockade of ILK suppressed TGF‐β 1 ‐induced MRTF‐SRF transcriptional activity, indicating a mutual relationship between MRTF‐SRF and FA. Myofibroblast differentiation along with CTGF expression was also dependent on MRTF‐SRF and FA components. Finally, global MRTF‐A deficient and inducible fibroblast‐specific MRTF‐B deficient mice (MRTF‐A KO B iFBKO mice) are protected from renal fibrosis with adenine administration. Renal expressions of ECM‐FA components and CTGF as well as myofibroblast accumulation were suppressed in MRTF‐A KO B iFBKO mice. These results suggest that the MRTF‐SRF pathway might be a therapeutic target for renal fibrosis through the regulation of components forming ECM‐FA in fibroblasts.